« FDA Adapts to an Expanding Generic Drug IndustryRead full story | Main | FDA warns consumers not to eat one batch of Loyd »

FDA permits marketing of a system to repair failed, problematic


FDA permits marketing of a system to repair failed, problematic fix for aortic aneurysms
The U.S. Food and Drug Administration today allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to repair a dangerously large aortic aneurysm, a bulge in the large blood vessel that carries blood away from the heart.
 

©2006 FDA-News.com. All rights reserved.